Apollo Medical Inc. (AMEH)
NASDAQ: AMEH
· Real-Time Price · USD
40.82
-0.88 (-2.11%)
At close: Feb 23, 2024, 10:00 PM
Apollo Medical Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|
| Health Care Capitation Revenue Revenue | 1.86B | 930.13M | 593.22M | 557.33M | 454.17M | 344.31M |
| Health Care Capitation Revenue Revenue Growth | +99.63% | +56.79% | +6.44% | +22.71% | +31.91% | n/a |
| Health Care, Other Revenue | 86.22M | 117.25M | 111.63M | 77.37M | 51.1M | 19.7M |
| Health Care, Other Revenue Growth | -26.46% | +5.04% | +44.28% | +51.41% | +159.33% | n/a |
| Health Care, Patient Service Revenue | 62.33M | 49.52M | 26.56M | 12.68M | 15.48M | 49.74M |
| Health Care, Patient Service Revenue Growth | +25.88% | +86.41% | +109.45% | -18.04% | -68.89% | n/a |
| Management Service Revenue | 13.98M | 41.09M | 35.96M | 34.85M | 34.67M | 5.23M |
| Management Service Revenue Growth | -65.98% | +14.28% | +3.18% | +0.52% | +563.37% | n/a |
| Product and Service, Other Revenue | 15.22M | 6.17M | 6.54M | 4.95M | 5.21M | n/a |
| Product and Service, Other Revenue Growth | +146.81% | -5.72% | +32.03% | -4.89% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 43.9M | 79.46M | 37.8M | 35.95M | 37.95M | 29.41M | 24.06M | 21.18M | 24.45M | 21.39M | 19.89M | 11.94M | 16.6M | 21.81M | 14.2M | 9.46M | 9.46M | 16.27M | 11.56M | 11.83M | 11.45M | 7.95M | 11.82M | 10.26M | 11.87M | 9.03M | 11.47M | 11.74M | 5.35M | 4.89M | 5.81M | 4.49M | 4.46M | 3.84M | 5.77M | 3.51M | 3.44M | 4.24M | 2.93M |
| Selling, General, and Administrative Revenue Growth | -44.76% | +110.20% | +5.15% | -5.26% | +29.03% | +22.26% | +13.57% | -13.35% | +14.30% | +7.51% | +66.57% | -28.06% | -23.89% | +53.62% | +50.03% | +0.08% | -41.88% | +40.79% | -2.35% | +3.34% | +44.04% | -32.73% | +15.14% | -13.54% | +31.44% | -21.27% | -2.25% | +119.54% | +9.34% | -15.79% | +29.42% | +0.69% | +16.13% | -33.57% | +64.52% | +2.02% | -18.80% | +44.55% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |